{"id":"W1490900965","doi":"10.1002/ajh.23788","title":"Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bosutinib; Medicine; Internal medicine; Gastroenterology; Imatinib; Neutropenia; Dysgeusia; Adverse effect; myalgia; Myeloid leukemia; Nilotinib; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002152596,0.0004791903,0.001148341,0.0002835309,0.0002768768,0.0008512926,0.0003214653,0.0005261429,0.002682745],"category_scores_gemma":[0.001500134,0.0002207025,0.001042429,0.0002728878,0.0003236018,0.0007306722,0.0003051915,0.001861315,0.0004414376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006839018,"about_ca_system_score_gemma":0.0009384956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005814739,"about_ca_topic_score_gemma":0.002711515,"domain_scores_codex":[0.9993618,0.0003813677,0.000035987,0.00006116834,0.00007551063,0.00008413543],"domain_scores_gemma":[0.9992892,0.0001556388,0.0002534002,0.00002744637,0.0000418275,0.0002325587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7732891,0.00639133,0.01199342,0.001081402,0.00243923,0.0002202389,0.0002489527,0.002859836,0.01991384,0.0009543605,0.008473926,0.1721342],"study_design_scores_gemma":[0.5900055,0.2914841,0.08501814,0.0003941433,0.002375848,0.0009266887,0.0001619572,0.004948336,0.005177575,0.001309253,0.01810919,0.00008938464],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9813249,0.01185799,0.0004791568,0.001038077,0.0002206471,0.0004516119,0.0011616,0.0000938508,0.003372167],"genre_scores_gemma":[0.9923378,0.002625244,0.0005588325,0.001071566,0.0001710842,0.0004625909,0.001682134,0.00001722087,0.001073576],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002682745,"threshold_uncertainty_score":0.01138413,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01798348010860252,"score_gpt":0.3333889627846194,"score_spread":0.3154054826760169,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}